...
首页> 外文期刊>Pharmacological reports: PR >REVIEW - Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy.
【24h】

REVIEW - Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy.

机译:回顾-冠状动脉微血管功能障碍和特发性扩张型心肌病。

获取原文
           

摘要

There is growing evidence of the presence and relevance of coronary microvascular abnormalities in many cardiac diseases. In particular, it has been recently shown that dilated cardiomyopathy (DCM) is characterized by dysfunction of the coronary microvessels since its very early onset. Coronary microcirculatory dysfunction is not an effect of myocardial damage but seems in turn to cause progressive contractile impairment, ventricular dilation and heart failure. The mechanisms of the progressive deterioration of cardiac function in DCM are largely unknown but both myocardial hypoperfusion and myocardial ischemia at the microvascular level are most probably involved. It has been demonstrated that the presence and the extent of coronary microcirculatory dysfunction in patients with early stage DCM is an independent and relevant predictor of worse prognosis. From these studies it is more and more evident that the coronary microcirculation is involved in the pathogenesis ofDCMand should be considered a new target of treatment in those cardiac diseases at risk to evolve towards heart failure.
机译:越来越多的证据表明,在许多心脏病中,冠状动脉微血管异常的存在和相关性。尤其是,最近显示,扩张性心肌病(DCM)的特征在于,自其非常早发作以来,冠状动脉微血管功能障碍。冠状动脉微循环功能障碍不是心肌损害的影响,而是反过来引起进行性的收缩功能障碍,心室扩张和心力衰竭。 DCM中心脏功能进行性恶化的机制尚不清楚,但微血管水平的心肌灌注不足和心肌缺血最有可能参与其中。已经证明,患有早期DCM的患者中冠状动脉微循环功能障碍的存在和程度是不良预后的独立且相关的预测因子。从这些研究中,越来越多的证据表明,冠状动脉微循环参与了DCM的发病机制,应被认为是那些有发展为心力衰竭风险的心脏病的新治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号